Allied health – 3007. The biomarker of sublingual immune therapy
World Allergy Organization Journal(2013)
摘要
Background Allergic rhinitis (AR) is recognized as a major health problem worldwide. Allergen-specific immunotherapy (SIT) is the only available treatment that can alter the natural course of allergic disease. Recent findings in experimental models of allergic rhinitis suggest that complement 3a and 5a regulate the development of maladaptive Th2 and Th17 immunity. We investigated the changes of C3a, C5a, IL-17a in the serum of patients treated by Sublingual immune therapy (SLIT).
更多查看译文
关键词
Health Problem,Experimental Model,Rhinitis,Allergic Rhinitis,Allergic Rhinitis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要